ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma
Clinical trial NCT02431403 · UNKNOWN
Trial details
- NCT number
- NCT02431403
- Sponsor
- Pusan National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2020-02-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.